Anticoagulant Micrurus venoms: Targets and neutralization.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
01 Feb 2021
Historique:
received: 20 08 2020
revised: 30 10 2020
accepted: 09 11 2020
pubmed: 17 11 2020
medline: 12 1 2021
entrez: 16 11 2020
Statut: ppublish

Résumé

Snakebite is a neglected tropical disease with a massive global burden of injury and death. The best current treatments, antivenoms, are plagued by a number of logistical issues that limit supply and access in remote or poor regions. We explore the anticoagulant properties of venoms from the genus Micrurus (coral snakes), which have been largely unstudied, as well as the effectiveness of antivenom and a small-molecule phospholipase inhibitor-varespladib-at counteracting these effects. Our in vitro results suggest that these venoms likely interfere with the formation or function of the prothrombinase complex. We find that the anticoagulant potency varies widely across the genus and is especially pronounced in M. laticollaris. This variation does not appear to correspond to previously described patterns regarding the relative expression of the three-finger toxin and phospholipase A

Identifiants

pubmed: 33197555
pii: S0378-4274(20)30467-7
doi: 10.1016/j.toxlet.2020.11.010
pii:
doi:

Substances chimiques

Acetates 0
Anticoagulants 0
Elapid Venoms 0
Indoles 0
Keto Acids 0
Phospholipase A2 Inhibitors 0
Receptors, Phospholipase A2 0
micrurus venom 0
varespladib 2Q3P98DATH
Thromboplastin 9035-58-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-97

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniel Dashevsky (D)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072 Australia; Australian National Insect Collection, Commonwealth Science and Industry Research Organization, Canberra, ACT 2601 Australia.

Melisa Bénard-Valle (M)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos, 62210, Mexico.

Edgar Neri-Castro (E)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos, 62210, Mexico.

Nicholas J Youngman (NJ)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072 Australia.

Christina N Zdenek (CN)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072 Australia.

Alejandro Alagón (A)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos, 62210, Mexico.

José A Portes-Junior (JA)

Laboratório de Coleções Zoológicas, Instituto Butantan, São Paulo 05503-900, Brazil.

Nathaniel Frank (N)

MToxins Venom Lab, 717 Oregon Street Oshkosh, WI 54902 USA.

Bryan G Fry (BG)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072 Australia. Electronic address: bgfry@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH